Head & Neck Cancer Study

A pivotal, double-blind, randomized, placebo-controlled, multinational study of SGX942(dusquetide) for the treatment of oral mucositis in patients being treated with concomitant chemoradiation for the treatment of squamous cell carcinoma of the head head and neck